Stock Spotlights Archives - Page 108 of 116

MondayNov 13, 2017 12:25 pm

CannabisNewsBreaks – ChineseInvestors.com, Inc.’s (CIIX) Investor Relations Division Generates Substantial Revenues

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) reported a 76% year-over-year jump in operating sales in fiscal 2017. The company’s Investor Relations division boasted as the largest generator of corporate three-month revenues, contributing 62% of CIIX’s total sales for the period. An article discussing this reads: “ChineseInvestors.com, Inc. (OTCQB: CIIX) is driving revenue growth from its Investor Relations Division, realizing a 186% jump in sales for 1QFY2018. The first quarter revenue in FY2018 in this segment was $258,366 compared to sales of $90,312 in the first quarter of FY2017. To generate growth in FY2018, CIIX developed new products, such as…

ThursdayNov 09, 2017 2:20 pm

CannabisNewsBreaks – AppSwarm, Inc. (SWRM) Applies Technical Expertise to Enter Cannabis Mobile App Market with Partner SinglePoint, Inc. (SING)

Developer and publisher of mobile gaming apps AppSwarm, Inc. (OTC: SWRM) is utilizing its technical expertise to enter the cannabis mobile app market in partnership with SinglePoint, Inc. (OTC: SING). An article discussing this reads: “As the two companies join forces, described in the LOI, it provides SWRM a significant platform for providing its technical and app development knowledge. They will first develop a service-based app for the business-to-business and business-to-consumer markets and provide a base for the development of future apps. The products will represent SWRM’s entry into the cannabis market and will be branded and marketed under SinglePoint’s…

ThursdayNov 09, 2017 11:56 am

CannabisNewsBreaks – Grey Cloak Tech, Inc.’s (GRCK) Subsidiary Eqova Products to be Presented at MJBizCon

In an all-stock transaction last month, Grey Cloak Tech, Inc. (OTCQB: GRCK) acquired 100% of Eqova Life Sciences. The company is attending a conference in Las Vegas where Eqova’s products will be seen by potentially thousands of cannabis-related executives. An article discussing this reads: “Grey Cloak Tech, Inc. (OTCQB: GRCK), through subsidiary Eqova Life Sciences, will introduce CannaBio Salve at the Marijuana Business Conference (MJBizCon), to be held November 14-17 in Las Vegas (http://cnw.fm/LB0Jm). Per the announcement, it is the industry’s premier cannabis trade show. CannaBio Salve is a topical skin product containing full spectrum hemp oil, menthol and essential…

ThursdayNov 09, 2017 10:00 am

CannabisNewsBreaks – Wildflower Brands Inc.’s (CSE: SUN) (OTCQB: WLDFF) CBD+ Capsules Featured Amongst Best Products on Hightimes.com Article

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) was highlighted in an article titled, ‘10 Best CBD Products Of 2017’ authored by Chloé Harper Gold on Hightimes.com. Wildflower's CBD+ Capsules were featured in the article, highlighting the ease of the mess-free capsules which appeals to consumers who seek the full benefit of CBD without the vaporizers. Each capsule contains 30 mg of CBD, amino acids, Omega 3, Omega 6, and hemp-seed oil. The convenience of the capsules makes for a fast and easy approach at incorporating CBD into a daily routine. CBD+ Capsules are available for purchase on the company's website (http://cnw.fm/iDx8v).…

WednesdayNov 08, 2017 12:53 pm

CannabisNewsBreaks – Marijuana Company of America, Inc. (MCOA) Building Momentum as Legalization Push Gains Steam

Marijuana Company of America (OTC: MCOA) is strongly positioned as the cannabis market continues to relentlessly expand throughout the country. In an effort to keep up with the increasing demand, the company entered an agreement with Bougainville Ventures to build a new structure. An article discussing this reads: “Pursuant to an agreement signed earlier this year, Marijuana Company of America, Inc. and Bougainville Ventures are constructing and will deliver a turnkey state-of-the-art cultivation and processing facility in Oroville, Washington. The 30,000 sq. ft. greenhouse will house a tier-3 production and processing I-502 tenant with decades of experience in cannabis cultivation.…

WednesdayNov 08, 2017 12:53 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Enters the Multibillion-Dollar Tea Market

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed delivery technologies to improve absorption of bioactive compounds and intends to use that technology in the tea market. The company plans to apply its patented DehydraTECH™ technology to supplement a range of black teas with cannabidiol (CBD) from hemp. An article discussing this reads: “Lexaria’s acquisition of Poviva Tea, LLC, announced on November 2 (http://cnw.fm/An29S), gives Lexaria a toehold in this vast $7 billion-plus market and consolidates ownership of Poviva Tea, LLC as a wholly owned Lexaria Bioscience subsidiary. The move also simplifies future operations and certain intellectual property ownership issues.…

WednesdayNov 08, 2017 12:52 pm

CannabisNewsBreaks – ChineseInvestors.com (CIIX) Provides Daily Video Telecast on Cryptocurrencies

Through a partnership with specialist broadcaster to the Chinese-speaking global community Wall Street Multimedia, Inc. (“WSM”), ChineseInvestors.com (OTCQB: CIIX) is launching “Bitcoin Multimillionaire,” a daily video telecast on cryptocurrencies emanating from the NYSE. An article discussing this reads: “CIIX’s goal is to become the primary Chinese publicly traded company that offers real time information on its website. In addition to its “Bitcoin Multimillionaire” broadcasts, it offers consulting services, subscriptions and retails hemp oil-based cannabidiol (CBD) products under the “OptHemp” brand and plans to market a line of hemp-infused skin care products through its wholly-owned subsidiary, CBD Biotechnology Co. Ltd.” To…

WednesdayNov 08, 2017 12:14 pm

CannabisNewsBreaks – Skinvisible, Inc. (SKVI) Develops Hemp-based Products with an Enhanced Delivery System

Skinvisible, Inc.’s (OTCQB: SKVI) proprietary topical drug delivery technology, Invisicare®, improves the delivery of pharmaceutical and medicinal compounds to and through the skin. The company develops hemp-based products and recently expanded its product line to the enter the cannabis-based topical product market. An article discussing this reads: “The patented polymer technology has been used in cosmeceutical, over-the-counter and pharmaceutical products for nearly two decades. On September 28, 2017, Skinvisible signed an exclusive agreement with Canopy Growth Corporation for the purpose of increasing its reach to Canada and establishing its position on the cannabis product markets. The definitive licensing agreement for…

TuesdayNov 07, 2017 11:20 am

CannabisNewsBreaks – PotNetwork Holding, Inc. (POTN) Strongly Positioned in a Market Projected to Reach $1.8B by 2020

PotNetwork Holding, Inc. (OTC: POTN) is positioned to profit from the continued growth in the cannabidiol (CBD) sector. Boasting an established product line and successful business model, the company and its Diamond CBD subsidiary stand out from competitors. An article discussing this reads: “The hemp-derived cannabidiol (CBD) market is projected to show phenomenal growth over the next few years. The Hemp Business Journal has projected a compound annual growth rate (CAGR) of 53 percent for CBD products derived from hemp, estimating this market to be worth $1.8 billion by 2020 (http://cnw.fm/mu4Ia). PotNetwork Holding, Inc. (OTC: POTN) is in a strong…

MondayNov 06, 2017 12:03 pm

CannabisNewsBreaks – India Globalization Capital (NYSE: IGC) Avoids Regulatory Costs through Cannabis-based Drug Candidates

India Globalization Capital (NYSE AMERICAN: IGC) is developing a portfolio of products using cannabis-based “combination therapies” for the treatment of various life-altering conditions. The company is employing a distinctive strategy to bring these drug candidates to market. An article discussing this reads: “IGC’s unique strategy reduces regulatory approval time and development costs because its chosen categories face lower regulatory burdens. Instead of pursuing full novel drug applications, which take anywhere from 7-9 years in clinical trials and cost hundreds of millions before securing FDA approval, IGC is developing cannabis-based drugs that could be commercialized in less than two years and…

News and publishing service for cannabis related companies

Contact us: 303.498.7722

Breaks Categories: Stock Spotlights